Hepatitis C Virus Infection Among Injecting Drug Users: Has Harm Reduction Worked?

References

• Alter M. J., Margolis H. S., Krawcynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner RE, et al. The natural history of community-acquired hepatitis C in the United States. New England Journal of Medicine 1992; 327: 1899–1905
   PubMed Web of Science ®Google Scholar
• Alter M. J. Epidemiology of hepatitis C. Hepatology 1997; 26: 62–5
   PubMed Web of Science ®Google Scholar
• Alter M. J., Moyer L. A. The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 18: S6–S10, Suppl I
   PubMedGoogle Scholar
• Australian National Council on AIDS and Related Diseases Hepatitis C Sub-Committee. Hepatitis C virus projections working group: Estimates and projections of the hepatitis C virus epidemic in Australia. National Centre in HIV epidemiology and clinical research, New South Wales 1998
   Google Scholar
• Bloor M., Frischer M., Taylor A., Covell R., Goldberg D., Green S., McKeganey N., Piatt S. Tideline and turn: possible reasons for the continuing low HIV prevalence among Glasgow's injecting drug users. Sociological Review 1994; 42: 738–757
   Web of Science ®Google Scholar
• Broers B., Junet C, Bourquin M., Déglon J. J., Perrin L., Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS. 1998; 12: 2059–2066
   Google Scholar
• Centers for Disease Control 1998 Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47: 1–39
   PubMedGoogle Scholar
• Crofts N., Hopper J. L., Bowden D. S., Breschkin A. M., Milner R., Locarnini S. A. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Medical Journal of Australia 1993; 159: 237–241
   PubMed Web of Science ®Google Scholar
• Crofts N., Aitken C. K. Incidence of bloodbome virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Medical Journal of Australia 1997; 167: 17–20
   PubMed Web of Science ®Google Scholar
• Crofts N., Jolley D., Kaldor J., Van Beek I., Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health 1997a; 51: 692–697
   PubMed Web of Science ®Google Scholar
• Crofts N., Nigro L., Oman K., Stevenson E., Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 1997b; 92: 999–1005
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Hagan H., Friedman S. R., Friedmann P., Goldberg D., Frischer M., Green S., Tunving K., Ljungberg B., Wodak A., Ross M., Purchase D., Millson M. E., Myers T. Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association 1995; 274: 1226–1231
   PubMed Web of Science ®Google Scholar
• Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human inmmunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health 1996; 86: 655–61
   PubMed Web of Science ®Google Scholar
• Garfein RS, Doherty MC., Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(SI)S11–19
   Google Scholar
• Goldberg D., Cameron S., McMenamin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Communicable Disease and Public Health 1998; 1: 95–97
   PubMedGoogle Scholar
• Gordon S. C, Patel A. H., Kulesza G. W., Barnes R. E., Silverman A. L. Lack of evidence for the heterosexual transmission of hepatitis C. American Journal of Gastroenterology 1992; 87: 1849–51
   PubMed Web of Science ®Google Scholar
• Hunter G., Stimson G. V., Jones S., Judd A., Hickman M. Survey of prevalence of sharing by injecting drug users not in contact with services: An independent study carried out on behalf of the Department of Health. Centre for Research on Drugs and Health Behaviour, London 1998
   Google Scholar
• Hurley S. F., Jolley D. J., Kaldor J. M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797–1800
   PubMed Web of Science ®Google Scholar
• Judd A, Hunter GM, Maconochie N, Hickman M, Parry JV, Renton A, Stimson GV. HIV prevalence and risk behaviour among female injecting drug users in London. AIDS. 1990–1996
   Google Scholar
• Kaplan E. H. Needles that kill: modelling the human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Reviews of Infectious Diseases 1989; 11: 289–298
   PubMedGoogle Scholar
• Koester S. K., Hoffer L. Indirect sharing: additional HIV risks associated with drug injection. AIDS & Public Policy Journal 1994; 9: 100–5
   Google Scholar
• Lam JP, McOmish F, Burns SM, Yap PL, Mok JY, Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993; 17: 722–77
   Google Scholar
• Loxley W. M., Phillips M., Carruthers S. J., Bevan J. S. The Australian study of HIV and injecting drug use. Part 1: prevalence of HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities. Drug and Alcohol Review 1997; 16: 207–214
   PubMed Web of Science ®Google Scholar
• Parker H., Bury C, Egginton R. New heroin outbreaks amongst young people in England and Wales. Home Office Police Research Group, London 1998
   Google Scholar
• Rhodes T., Hunter G. M., Stimson G. V., Donoghoe M. C., Noble A., Parry J., Chalmers C. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour. Addiction 1996; 91: 1457–1467
   PubMed Web of Science ®Google Scholar
• Selvey L. A., Denton M., Plant A. J. Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. Australian and New Zealand Journal of Public Health 1997; 21: 102–104
   PubMed Web of Science ®Google Scholar
• Smyth B. P., Keenan E., O'Connor J. Bloodborne viral infection in Irish injecting drug users. Addiction 1998; 93: 1649–1656
   PubMed Web of Science ®Google Scholar
• Stimson G. V. Has the United Kingdom averted an epidemic of HIV-1 infection among drug injectors?. Addiction 1996; 91: 1085–1088
   PubMed Web of Science ®Google Scholar
• Unlinked Anonymous Surveys Steering Group. Prevalence of HIV in England and Wales in 1996. Annual report of the Unlinked Anonymous Prevalence Monitoring Programme. Department of Health, London 1997
   Google Scholar
• Van Ameijden E. J., Van den Hoek J. A., Mientjes G. H., Coutinho R. A. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. European Journal of Epidemiology 1993; 9: 255–262
   PubMed Web of Science ®Google Scholar
• Van Beek I., Buckley R., Stewart M., MacDonald M., Kaldor J. risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourinary Medicine 1994; 70: 321–324
   PubMedGoogle Scholar
• Van Beek I., Dwyer R., Dore G. J., Luo K., Kaldor J. M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. British Medical Journal 1998; 317: 433–437
   PubMed Web of Science ®Google Scholar
• Weinstock H. S., Bolan G., Reingold A. L., Polish L. B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. Journal of the American Medical Association 1993; 269: 392–4
   PubMed Web of Science ®Google Scholar
• World Health Organization Hepatitis C: global prevalence. Weekly Epidemiological Record 1997; 72: 341–348
   PubMedGoogle Scholar